Signaling and transcription in T helper development

Annual Review of Immunology

Volumn 18, Issue , 2000, Pages 451-494

  Murphy, Kenneth M ^a   Ouyang, Wenjun ^a   Farrar, J David ^a   Yang, Jianfei ^a   Ranganath, Sheila ^a   Asnagli, Helene ^a   Afkarian, Maryam ^a   Murphy, Theresa L ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; Gene expression; Signaling; Th subsets; Transcription

Indexed keywords

ALPHA INTERFERON; ALPHA INTERFERON RECEPTOR; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 4; STAT4 PROTEIN;

ANTIGEN PRESENTING CELL; CELL MATURATION; CYTOKINE RELEASE; DENDRITIC CELL; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HELPER CELL; HUMAN; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TH1 CELL; TH2 CELL;

ANIMALS; CARRIER PROTEINS; CELL DIVISION; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; INTERFERON TYPE I; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-12; INTERLEUKIN-13; INTERLEUKIN-4; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; STAT4 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; T-LYMPHOCYTES, HELPER-INDUCER; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC;

EID: 0034129629     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.18.1.451     Document Type: Review

References (310)

1. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:2348
2. Romagnani S. 1994. Lymphokine production by human T cells in disease states. Annu. Rev. Immunol. 12:227
3. + T cells. Annu. Rev. Immunol. 12:635
4. Hardy KJ, Peterlin BM, Atchison RE, Stobo JD. 1985. Regulation of expression of the human interferon gamma gene. PNAS 82:8173
5. Hardy KJ, Manger B, Newton M, Stobo JD. 1987. Molecular events involved in regulating human interferon-gamma gene expression during T cell activation. J. Immunol. 138:2353
6. Young HA, Komschlies KL, Ciccarone V, Beckwith M, Rosenberg M, Jenkins NA, Copeland NG, Durum SK. 1989. Expression of human IFN-gamma genomic DNA in transgenic mice. J. Immunol. 143:2389
7. Ciccarone VC, Chrivia J, Hardy KJ, Young HA. 1990. Identification of enhancer-like elements in human IFN-gamma genomic DNA. J. Immunol. 144:725
8. Chrivia JC, Wdrychowicz T, Young HA, Hardy KJ. 1990. A model of human cytokine regulation based on transfection of gamma interferon gene fragments directly into isolated peripheral blood T lymphocytes. J. Exp. Med. 172:661
9. Penix L, Weaver WM, Pang Y, Young HA, Wilson CB. 1993. Two essential regulatory elements in the human interferon gamma promoter confer activation specific expression in T cells. J. Exp. Med. 178:1483
10. Aune TM, Penix LA, Rincon MR, Flavell RA. 1997. Differential transcription directed by discrete gamma interferon promoter elements in naive and memory (effector) CD4 T cells and CD8 T cells. Mol. Cell. Biol. 17:199
11. Penix LA, Sweetser MT, Weaver WM, Hoeffler JP, Kerppola TK, Wilson CB. 1996. The proximal regulatory element of the interferon-gamma promoter mediates selective expression in T cells. J. Biol. Chem. 271:31964
12. Zhang F, Wang DZ, Boothby M, Penix L, Flavell RA, Aune TM. 1998. Regulation of the activity of IFN-gamma promoter elements during Th cell differentiation. J. Immunol. 161:6105
13. Sweetser MT, Hoey T, Sun YL, Weaver WM, Price GA, Wilson CB. 1998. The roles of nuclear factor of activated T cells and ying-yang 1 in activation-induced expression of the interferon-gamma promoter in T cells. J. Biol. Chem. 273:34775
14. Sica A, Tan TH, Rice N, Kretzschmar M, Ghosh P, Young HA. 1992. The c-rel protooncogene product c-Rel but not NF-kappa B binds to the intronic region of the human interferon-gamma gene at a site related to an interferon-stimulable response element. PNAS 89:1740
15. Campbell PM, Pimm J, Ramassar V, Halloran PF. 1996. Identification of a calcium-inducible, cyclosporine sensitive element in the IFN-gamma promoter that is a potential NFAT binding site. Transplantation 61:933
16. Sica A, Dorman L, Viggiano V, Cippitelli M, Ghosh P, Rice N, Young HA. 1997. Interaction of NF-kappaB and NFAT with the interferon-gamma promoter. J. Biol. Chem. 272:30412
17. Agarwal S, Rao A. 1998. Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation. Immunity 9:765
18. Rincon M, Enslen H, Raingeaud J, Recht M, Zapton T, Su MS, Penix LA, Davis RJ, Flavell RA. 1998. Interferon-gamma expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway. EMBO J. 17:2817
19. + T cells to Th1 cells requires MAP kinase JNK2. Immunity 9:575
20. Dong C, Yang DD, Wysk M, Whitmarsh AJ, Davis RJ, Flavell RA. 1998. Defective T cell differentiation in the absence of Jnk1. Science 282:2092
21. Lu HT, Yang DD, Wysk M, Gatti E, Mellman I, Davis RJ, Flavell RA. 1999. Defective IL-12 production in mitogen-activated protein (MAP) kinase kinase 3 (Mkk3)-deficient mice. EMBO J. 18: 1845
22. Taki S, Sato T, Ogasawara K, Fukuda T, Sato M, Hida S, Suzuki G, Mitsuyama M, Shin EH, Kojima S, Taniguchi T, Asano Y. 1997. Multistage regulation of Th1-type immune responses by the transcription factor IRF-1. Immunity 6:673
23. Lohoff M, Ferrick D, Mittrucker HW, Duncan GS, Bischof S, Rollinghoff M, Mak TW. 1997. Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo. Immunity 6:681
24. Coccia EM, Passini N, Battistini A, Pini C, Sinigaglia F, Rogge L. 1999. Interleukin-12 induces expression of interferon regulatory factor-1 via signal transducer and activator of transcription-4 in human T helper type 1 cells. J. Biol. Chem. 274:6698
25. Ouyang W, Jacobson NG, Bhattacharya D, Gorham JD, Fenoglio D, Sha WC, Murphy TL, Murphy KM. 1999. The Ets transcription factor ERM is Th1-specific and induced by IL-12 through a Stat4-dependent pathway. PNAS 96:3888
26. Barton K, Muthusamy N, Fischer C, Ting CN, Walunas TL, Lanier LL, L Leiden JM. 1998. The Ets-1 transcription factor is required for the development of natural killer cells in mice. Immunity 9:555
27. Gourley T, Roys S, Lukacs NW, Kunkel SL, Flavell RA, Chang CH. 1999. A novel role for the major histocompatibility complex class II transactivator CIITA in the repression of IL-4 production. Immunity 10:377
28. Ye J, Ghosh P, Cippitelli M, Subleski J, Hardy KJ, Ortaldo JR, Young HA. 1994. Characterization of a silencer regulatory element in the human interferon-gamma promoter. J. Biol. Chem. 269:25728
29. Ye J, Cippitelli M, Dorman L, Ortaldo JR, Young HA. 1996. The nuclear factor YY1 suppresses the human gamma interferon promoter through two mechanisms: inhibition of AP1 binding and activation of a silencer element. Mol. Cell. Biol. 16:4744
30. Ouyang W, Ranganath SH, Weindel K, Bhattacharya D, Murphy TL, Sha WC, Murphy KM. 1998. Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity 9:745
31. Ho IC, Hodge MR, Rooney JW, Glimcher LH. 1996. The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell 85:973
32. Ho IC, Lo D, Glimcher LH. 1998. c-maf promotes T helper cell type 2 (Th2) and attenuates Th1 differentiation by both interleukin 4-dependent and -independent mechanisms. J. Exp. Med. 188:1859
33. Young HA, Ghosh P, Ye J, Lederer J, Lichtman A, Gerard JR Jr, Penix L, Wilson CB, Melvin AJ, McGurn ME. 1994. Differentiation of the T helper phenotypes by analysis of the methylation state of the IFN-gamma gene. J. Immunol. 153:3603
34. Pang Y, Norihisa Y, Benjamin D, Kantor RR, Young HA. 1992. Interferon-gamma gene expression in human B-cell lines: induction by interleukin-2, protein kinase C activators, and possible effect of hypomethylation on gene regulation. Blood 80:724
35. + T cells. J. Exp. Med. 188:103
36. Leonard WJ, O'Shea JJ. 1998. Jaks and STATs: biological implications. Annu. Rev. Immunol. 16:293
37. Hoey T, Grusby MJ. 1999. STATs as mediators of cytokine-induced responses. Adv. Immunol. 71:145
38. Zhong Z, Wen Z, Darnell JE Jr. 1994. Stat3 and Stat4: members of the family of signal transducers and activators of transcription. PNAS 91:4806
39. Jacobson NG, Szabo SJ, Weber-Nordt RM, Zhong Z, Schreiber RD, Darnell JE Jr, Murphy KM. 1995. Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4. J. Exp. Med. 181:1755
40. Szabo SJ, Jacobson NG, Dighe AS, Gubler U, Murphy KM. 1995. Developmental commitment to the Th2 lineage by extinction of IL-12 signaling. Immunity 2:665
41. Thierfelder WE, van Deursen JM, Yamamoto K, Tripp RA, Sarawar SR, Carson RT, Sangster MY, Vignali DA, Doherty PC, Grosveld GC, Ihle JN. 1996. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 382:171
42. Kaplan MH, Sun YL, Hoey T, Grusby MJ. 1996. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382:174
43. Kaplan MH, Wurster AL, Grusby MJ. 1998. A signal transducer and activator of transcription (Stat)4-independent pathway for the development of T helper type 1 cells. J. Exp. Med. 188:1191
44. + T cells. J. Exp. Med. 189:1355
45. Xu X, Sun YL, Hoey T. 1996. Cooperative DNA binding and sequence-selective recognition conferred by the STAT amino-terminal domain. Science 273:794
46. + T cells: evidence for two distinct pathways for promoter activation. Eur. J. Immunol. 29:548
47. Rogge L, D'Ambrosio D, Biffi M, Penna G, Minetti LJ, Presky DH, Adorini L, Sinigaglia F. 1998. The role of Stat4 in species-specific regulation of Th cell development by type I IFNs. J. Immunol. 161:6567
48. Bhattacharya S, Eckner R, Grossman S, Oldread E, Arany Z, D'Andrea A, Livingston DM. 1996. Cooperation of Stat2 and p300/CBP in signalling induced by interferon-alpha. Nature 383:344
49. Korzus E, Torchia J, Rose DW, Xu L, Kurokawa R, McInerney EM, Mullen TM, Glass CK, Rosenfeld MG. 1998. Transcription factor-specific requirements for coactivators and their acetyl-transferase functions. Science 279:703
50. Zhang JJ, Vinkemeier U, Gu W, Chakravarti D, Horvath CM, Darnell JE Jr. 1996. Two contact regions between Stat1 and CBP/p300 in interferon gamma signaling. PNAS 93:15092
51. Chen X, Vinkemeier U, Zhao Y, Jeruzalmi D, Darnell JE Jr, Kuriyan J. 1998. Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA. Cell 93:827
52. Zhu M, John S, Berg M, Leonard WJ. 1999. Functional association of Nmi with Stat5 and Stat1 in IL-2-and IFN-gamma-mediated signaling. Cell 96:121
53. Vinkemeier U, Moarefi T, Darnell JE Jr, Kuriyan J. 1998. Structure of the amino-terminal protein interaction domain of STAT-4. Science 279:1048
54. Vinkemeier U, Cohen SL, Moarefi I, Chait BT, Kuriyan J, Darnell JE Jr. 1996. DNA binding of in vitro activated Stat1 alpha, Stat1 beta and truncated Stat1: interaction between NH2-terminal domains stabilizes binding of two dimers to tandem DNA sites. EMBO J. 15:5616
55. Meyer WK, Reichenbach P, Schindler U, Soldaini E, Nabholz M. 1997. Interaction of STAT5 dimers on two low affinity binding sites mediates interleukin 2 (IL-2) stimulation of IL-2 receptor alpha gene transcription. J. Biol. Chem. 272:31821
56. John S, Vinkemeier U, Soldaini E, Darnell JE JR, Leonard WJ. 1999. The significance of tetramerization in promoter recruitment by Stat5. Mol. Cell. Biol. 19:1910
57. Parronchi P, De Carli M, Manetti R, Simonelli C, Sampognaro S, Piccinni MP, Macchia D, Maggi E, Del Prete G, Romagnani S. 1992. IL-4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones. J. Immunol. 149:2977
58. + T cells. J. Exp. Med. 178:1655
59. Rogge L, Barberis-Maino L, Biffi M, Passini N, Presky DH, Gubler U, Sinigaglia F. 1997. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J. Exp. Med. 185:825
60. Wenner CA, Guler ML, Macatonia SE, O'Garra A, Murphy KM. 1996. Roles of IFN-gamma and IFN-alpha in IL-12-induced T helper cell-1 development. J. Immunol. 156:1442
61. Bacon CM, Petricoin EF, Ortaldo JR, Rees RC, Lamer AC, Johnston JA, O'Shea JJ. 1995. Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes. PNAS 92:7307
62. Cho SS, Bacon CM, Sudarshan C, Rees RC, Finbloom D, Pine R, O'Shea JJ. 1996. Activation of STAT4 by IL-12 and IFN-alpha: evidence for the involvement of ligand-induced tyrosine and serine phosphorylation. J. Immunol. 157:4781
63. Steinhoff U, Muller U, Schertler A, Hengartner H, Aguet KM, Zinkernagel RM. 1995. Antiviral protection by vesicular stomatitis virus-specific antibodies in alpha/beta interferon receptor-deficient mice. J. Virol. 69:2153
64. Uze G, Lutfalla G, Gresser I. 1990. Genetic transfer of a functional human interferon alpha receptor into mouse cells: cloning and expression of its cDNA. Cell 60:225
65. Cook JR, Cleary CM, Mariano TM, Izotova L, Pestka S. 1996. Differential responsiveness of a splice variant of the human type I interferon receptor to interferons. J. Biol. Chem. 271:13448
66. Novick D, Cohen B, Rubinstein M. 1994. The human interferon alpha/beta receptor: characterization and molecular cloning. Cell 77:391
67. Soh J, Mariano TM, Lim JK, Izotova L, Mirochnitchenko O, Schwartz B, Langer JA, Pestka S. 1994. Expression of a functional human type I interferon receptor in hamster cells: application of functional yeast artificial chromosome (YAC) screening. J. Biol. Chem. 269:18102
68. Colamonici OR, Domanski P. 1993. Identification of a novel subunit of the type I interferon receptor localized to human chromosome 21. J. Biol. Chem. 268:10895
69. Kim SH, Cohen B, Novick D, Rubinstein M. 1997. Mammalian type I interferon receptors consist of two subunits: IFNaR1 and IFNaR2. Gene 196:279
70. Owczarek CM, Hwang SY, Holland KA, Gulluyan LM, Tavaria M, Weaver B, Reich NC, Kola I, Hertzog PJ. 1997. Cloning and characterization of soluble and transmembrane isoforms of a novel component of the murine type I interferon receptor, IFNAR 2. J. Biol. Chem. 272:23865
71. Domanski P, Fish E, Nadeau OW, Witte M, Platanias LC, Yan H, Krolewski J, Pitha P, Colamonici OR. 1997. A region of the beta subunit of the interferon alpha receptor different from box 1 interacts with Jak1 and is sufficient to activate the Jak-Stat pathway and induce an antiviral state. J. Biol. Chem. 272:26388
72. Colamonici O, Yan H, Domanski P, Handa R, Smalley D, Mullersman J, Witte M, Krishnan K, Krolewski J. 1994. Direct binding to and tyrosine phosphorylation of the alpha subunit of the type I interferon receptor by p135tyk2 tyrosine kinase. Mol. Cell. Biol. 14:8133
73. Yan H, Krishnan K, Lim JT, Contillo LG, Krolewski JJ. 1996. Molecular characterization of an alpha interferon receptor 1 subunit (IFNaR1) domain required for TYK2 binding and signal transduction. Mol. Cell Biol. 16:2074
74. Abramovich C, Shulman LM, Ratovitski E, Harroch S, Tovey M, Eid P, Revel M. 1994. Differential tyrosine phosphorylation of the IFNAR chain of the type I interferon receptor and of an associated surface protein in response to IFN-alpha and IFN-beta. EMBO J. 13:5871
75. Yan H, Krishnan K, Greenlund AC, Gupta S, Lim JT, Schreiber RD, Schindler CW, Krolewski JJ. 1996. Phosphorylated interferon-alpha receptor 1 subunit (IFNaR1) acts as a docking site for the latent form of the 113 kDa STAT2 protein. EMBO J. 15:1064
76. Leung S, Qureshi SA, Kerr IM, Darnell JEJ, Stark GR. 1995. Role of STAT2 in the alpha interferon signaling pathway. Mol. Cell. Biol. 15:1312
77. Qureshi SA, Leung S, Kerr IM, Stark GR, Darnell JE Jr. 1996. Function of Stat2 protein in transcriptional activation by alpha interferon. Mol. Cell. Biol. 16:288
78. Yang CH, Shi W, Basu L, Murti A, Constantinescu SN, Blatt L, Croze E, Mullersman JE, Pfeffer LM. 1996. Direct association of STAT3 with the IFNAR-1 chain of the human type I interferon receptor. J. Biol. Chem. 271:8057
79. Pfeffer LM, Mullersman JE, Pfeffer SR, Murti A, Shi W, Yang CH. 1997. STAT3 as an adapter to couple phosphatidylinositol 3-kinase to the IFNAR1 chain of the type I interferon receptor. Science 276:1418
80. Ahmad S, Alsayed YM, Druker BJ, Platanias LC. 1997. The type I interferon receptor mediates tyrosine phosphorylation of the CrkL adaptor protein. J. Biol. Chem. 272:29991
81. Lichtman AH, Chin J, Schmidt JA, Abbas AK. 1988. Role of interleukin 1 in the activation of T lymphocytes. PNAS 85:9699
82. + T cells specific for Plasmodium chabaudi. Immunology 81:216
83. Shibuya K, Robinson D, Zonin F, Hartley SB, Macatonia SE, Somoza C, Hunter CA, Murphy KM, O'Garra A. 1998. IL-1 alpha and TNF-alpha are required for IL-12-induced development of Th1 cells producing high levels of IFN-gamma in BALB/c but not C57BL/6 mice. J. Immunol. 160:1708
84. Okamura H, Tsutsi H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, Torigoe K, Okura T, Nukada Y, Hattori K. 1995. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 378:88
85. Okamura H, Nagata K, Komatsu T, Tanimoto T, Nukata Y, Tanabe F, Akita K, Torigoe K, Okura T, Fukuda S. 1995. A novel costimulatory factor for gamma interferon induction found in the livers of mice causes endotoxic shock. Infect. Immun. 63:3966
86. Bazan JF, Timans JC, Kastelein RA. 1996. A newly defined interleukin-1? Nature 379:591
87. Gu Y, Kuida K, Tsutsui H, Ku G, Hsiao K, Fleming MA, Hayashi N, Higashino K, Okamura H, Nakanishi K, Kurimoto M, Tanimoto T, Flavell RA, Sato V, Harding MW, Livingston DJ, Su MS. 1997. Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme. Science 275:206
88. Ghayur T, Banerjee S, Hugunin M, Butler D, Herzog L, Carter A, Quintal L, Sekut L, Talanian R, Paskind M, Wong W, Kamen R, Tracey D, Allen H. 1997. Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature 386:619
89. Fantuzzi G, Puren AJ, Harding MW, Livingston DJ, Dinarello CA. 1998. Interleukin-18 regulation of interferon gamma production and cell proliferation as shown in interleukin-1beta-converting enzyme (caspase-1)-deficient mice. Blood 91:2118
90. Puren AJ, Fantuzzi G, Dinarello CA. 1999. Gene expression, synthesis, and secretion of interleukin 18 and interleukin 1beta are differentially regulated in human blood mononuclear cells and mouse spleen cells. PNAS 96:2256
91. Micallef MJ, Ohtsuki T, Kohno K, Tanabe F, Ushio S, Namba M, Tanimoto T, Torigoe K, Fujii M, Ikeda M, Fukuda S, Kurimoto M. 1996. Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production. Eur. J. Immunol. 26:1647
92. Kohno K, Kataoka J, Ohtsuki T, Suemoto Y, Okamoto I, Usui M, Ikeda M, Kurimoto M. 1997. IFN-gamma-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12. J. Immunol. 158:1541
93. Takeda K, Tsutsui H, Yoshimoto T, Adachi O, Yoshida N, Kishimoto T, Okamura H, Nakanishi K, Akira S. 1998. Defective NK cell activity and Th1 response in IL-18-dencient mice. Immunity 8:383
94. Robinson D, Shibuya K, Mui A, Zonin F, Murphy E, Sana T, Hartley SB, Menon S, Kastelein R, Bazan F, O'Garra A. 1997. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFkappaB. Immunity 7:571
95. Hoshino T, Wiltrout RH, Young HA. 1999. IL-18 is a potent coinducer of IL-13 in NK and T cells: a new potential role for IL-18 in modulating the immune response. J. Immunol. 162:5070
96. Cao Z, Henzel WJ, Gao X. 1996. IRAK: a kinase associated with the interleukin-1 receptor. Science 271:1128
97. Huang J, Gao X, Li S, Cao Z. 1997. Recruitment of IRAK to the interleukin 1 receptor complex requires interleukin 1 receptor accessory protein. PNAS 94:12829
98. Wesche H, Korherr C, Kracht M, Falk W, Resch K, Martin MU. 1997. The interleukin-1 receptor accessory protein (IL-1RAcP) is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases). J. Biol. Chem. 272:7727
99. Muzio M, Ni J, Feng P, Dixit VM. 1997. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science 278:1612
100. Wesche H, Henzel WJ, Shillinglaw W, Li S, Cao Z. 1997. MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity 7:837
101. Cao Z, Xiong J, Takeuchi M, Kurama T, Goeddel DV. 1996. TRAF6 is a signal transducer for interleukin-1. Nature 383:443
102. Satoskar AR, Okano M, Connaughton S, Raisanen S, David JR, Labow M. 1998. Enhanced Th2-like responses in IL-1 type 1 receptor-deficient mice. Eur. J. Immunol. 28:2066
103. Huber M, Beuscher HU, Rohwer P, Kurrle R, Rollinghoff M, Lohoff M. 1998. Costimulation via TCR and IL-1 receptor reveals a novel IL-1alpha-mediated autocrine pathway of Th2 cell proliferation. J. Immunol. 160:4242
104. Matsumoto S, Tsuji-Takayama K, Aizawa Y, Koide K, Takeuchi M, Ohta T, Kurimoto M. 1997. Interleukin-18 activates NF-kappaB in murine T helper type 1 cells. Biochem. Biophys. Res. Commun. 234:454
105. Tsuji-Takayama K, Matsumoto S, Koide K, Takeuchi M, Ikeda M, Ohta T, Kurimoto M. 1997. Interleukin-18 induces activation and association of p56(1ck) and MAPK in a murine TH1 clone. Biochem. Biophys. Res. Commun. 237:126
106. Parnet P, Garka KE, Bonnert TP, Dower SK, Sims JE. 1996. IL-1Rrp is a novel receptor-like molecule similar to the type I interleukin-1 receptor and its homologues T1/ST2 and IL-1R AcP. J. Biol. Chem. 271:3967
107. Torigoe K, Ushio S, Okura T, Kobayashi S, Taniai M, Kunikata T, Murakami T, Sanou O, Kojima H, Fujii M, Ohta T, Ikeda M, Ikegami H, Kurimoto M. 1997. Purification and characterization of the human interleukin-18 receptor. J. Biol. Chem. 272:25737
108. Thomassen E, Bird TA, Renshaw BR, Kennedy MK, Sims JE. 1998. Binding of interleukin-18 to the interleukin-1 receptor homologous receptor IL-1Rrp1 leads to activation of signaling pathways similar to those used by interleukin-1. J. Interferon Cytokine Res. 18:1077
109. Born TL, Thomassen E, Bird TA, Sims JE. 1998. Cloning of a novel receptor subunit, AcPL, required for interleukin-18 signaling. J. Biol. Chem. 273:29445
110. Kojima H, Takeuchi M, Ohta T, Nishida Y, Arai N, Ikeda M, Ikegami H, Kurimoto M. 1998. Interleukin-18 activates the IRAK-TRAF6 pathway in mouse EL-4 cells. Biochem. Biophys. Res. Commun. 244:183
111. Adachi O, Kawai T, Takeda K, Matsumoto M, Tsutsui H, Sakagami M, Nakanishi K, Akira S. 1998. Targeted disruption of the MyD88 gene results in loss of IL-1-and IL-18-mediated function. Immunity 9:143
112. Kanakaraj P, Ngo K, Wu Y, Angulo A, Ghazal P, Harris CA, Siekierka JJ, Peterson PA, Fung-Leung Wp. 1999. Defective interleukin (IL)-18-mediated natural killer and T helper cell type 1 responses in IL-1 receptor-associated kinase (IRAK)-deficient mice. J. Exp. Med. 189:1129
113. Hoshino K, Tsutsui H, Kawai T, Takeda K, Nakanishi K, Takeda Y, Akira S. 1999. Cutting edge: generation of IL-18 receptor-deficient mice: evidence for IL-1 receptor-related protein as an essential IL-18 binding receptor. J. Immunol. 162:5041
114. + T lymphocytes. J. Immunol. 160:3642
115. Ahn HJ, Maruo S, Tomura M, Mu J, Hamaoka T, Nakanishi K, Clark S, Kurimoto M, Okamura H, Fujiwara H. 1997. A mechanism underlying synergy between IL-12 and IFN-gamma-inducing factor in enhanced production of IFN-gamma. J. Immunol. 159:2125
116. Yoshimoto T, Takeda K, Tanaka T, Ohkusu K, Kashiwamura S, Okamura H, Akira S, Nakanishi K. 1998. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. J. Immunol. 161:3400
117. Xu D, Chan WL, Leung BP, Hunter D, Schulz K, Carter RW, Mclnnes IB, Robinson JH, Liew FY. 1998. Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells. J. Exp. Med. 188:1485
118. Kojima H, Aizawa Y, Yanai Y, Nagaoka K, Takeuchi M, Ohta T, Ikegami H, Ikeda M, Kurimoto M. 1999. An essential role for NF-kappa B in IL-18-induced IFN-gamma expression in KG-1 cells. J. Immunol. 162:5063
119. Klemenz R, Hoffmann S, Werenskiold AK. 1989. Serum-and oncoprotein-mediated induction of a gene with sequence similarity to the gene encoding carcinoembryonic antigen. PNAS 86:5708
120. Mitcham JL, Parnet P, Bonnert TP, Garka KE, Gerhart MJ, Slack JL, Gayle MA, Dower SK, Sims JE. 1996. T1/ST2 signaling establishes it as a member of an expanding interleukin-1 receptor family. J. Biol. Chem. 271:5777
121. Xu D, Chan WL, Leung BP, Huang F, Wheeler R, Piedrafita D, Robinson JH, Liew FY. 1998. Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J. Exp. Med. 187:787
122. Lohning M, Stroehmann A, Coyle AJ, Grogan JL, Lin S, Gutierrez-Ramos JC, Levinson D, Radbruch A, Kamradt T. 1998. T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. PNAS 95:6930
123. + T cells from schistosome egg-induced granulomas: analysis of Th cell cytokine coexpression ex vivo. J. Immunol. 162:3882
124. Gayle MA, Slack JL, Bonnert TP, Renshaw BR, Sonoda G, Taguchi, Testa T Jr, Dower SK, Sims JE. 1996. Cloning of a putative ligand for the T1/ST2 receptor. J. Biol. Chem. 271:5784
125. Magram J, Connaughton SE, Warrier RR, Carvajal DM, Wu CY, Ferrante J, Stewart C, Sarmiento U, Faherty DA, Gately MK. 1996. IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity 4:471
126. Piccotti R, Li K, Chan SY, Ferrante J, Magram J, Eichwald EJ, Bishop DK. 1998. Alloantigen-reactive Th1 development in IL-12-deficient mice. J. Immunol. 160:1132
127. Wu C, Ferrante J, Gately MK, Magram J. 1997. Characterization of IL-12 receptor betal chain (IL-12Rbeta1)-deficient mice: IL-12Rbeta1 is an essential component of the functional mouse IL-12 receptor. J. Immunol. 159:1658
128. de Jong R, Altare F, Haagen IA, Elferink DG, Boer T, van Breda V, Kabel PJ, Draaisma JM, van Dissel JT, Kroon FP, Casanova JL, Ottenhoff TH. 1998. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 280:1435
129. Altare F, Durandy A, Lammas D, Emile JF, Lamhamedi S, Le Deist F, Drysdale P, Jouanguy E, Doffinger R, Bernaudin F, Jeppsson O, Gollob JA, Meinl E, Segal AW, Fischer A, Kumararatne D, Casanova JL. 1998. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 280:1432
130. Altare F, Lammas D, Revy P, Jouanguy E, Doffinger R, Lamhamedi S, Drysdale P, Scheel-Toellner D, Girdlestone J, Darbyshire P, Wadhwa M, Dockrell H, Salmon M, Fischer A, Durandy A, Casanova JL, Kumararatne DS. 1998. Inherited interleukin 12 deficiency in a child with bacille Calmette-Guerin and Salmonella enteritidis disseminated infection. J. Clin. Invest. 102:2035
131. Trinchieri G. 1995. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251
132. Murphy TL, Cleveland MG, Kulesza P, Magram J, Murphy KM. 1995. Regulation of interleukin 12 p40 expression through an NF-kappa B half-site. Mol. Cell. Biol. 15:5258
133. Ma X, Gri G, Trinchieri G. 1996. A novel ets-2-related nuclear factor is involved in transcriptional activation of the human interleukin-12 p40 gene promoter in response to interferon-gamma and LPS stimulation of monocytic cells. Ann. NY Acad. Sci. 795:357
134. Ma X, Chow JM, Gri G, Carra G, Gerosa F, Wolf SF, Dzialo R, Trinchieri G. 1996. The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells. J. Exp. Med. 183:147
135. Holtschke T, Lohler J, Kanno Y, Fehr T, Giese N, Rosenbauer F, Lou J, Knobeloch KP, Gabriele L, Waring JF, Bachmann MF, Zinkernagel RM, Morse HC, Ozato K, Horak I. 1996. Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell 87:307
136. Wu CY, Maeda H, Contursi C, Ozato K, Seder RA. 1999. Differential requirement of IFN consensus sequence binding protein for the production of IL-12 and induction of Th1-type cells in response to IFN-gamma. J. Immunol. 162:807
137. Giese NA, Gabriele L, Doherty TM, Klinman DM, Tadesse-Heath L, Contursi C, Epstein SL, Morse HC. 1997. Interferon (IFN) consensus sequence-binding protein, a transcription factor of the TFN regulatory factor family, regulates immune responses in vivo through control of interleukin 12 expression. J. Exp. Med. 186:1535
138. Scharton-Kersten T, Contursi C, Masumi A, Sher A, Ozato K. 1997. Interferon consensus sequence binding protein-deficient mice display impaired resistance to intracellular infection due to a primary defect in interleukin 12 p40 induction. J. Exp. Med. 186:1523
139. Yoshimoto T, Kojima K, Funakoshi T, Endo Y, Fujita T, Nariuchi H. 1996. Molecular cloning and characterization of murine IL-12 genes. J. Immunol. 156:1082
140. Tone Y, Thompson SA, Babik JM, Nolan KF, Tone M, Raven C, Waldmann H. 1996. Structure and chromosomal location of the mouse interleukin-12 p35 and p40 subunit genes. Eur. J. Immunol. 26:1222
141. Ma X, Neurath M, Gri G, Trinchieri G. 1997. Identification and characterization of a novel Ets-2-related nuclear complex implicated in the activation of the human interleukin-12 p40 gene promoter. J. Biol. Chem. 272:10389
142. Plevy SE, Gemberling JH, Hsu S, Dorner AJ, Smale ST. 1997. Multiple control elements mediate activation of the murine and human interleukin 12 p40 promoters: evidence of functional synergy between C/EBP and Rel proteins. Mol. Cell. Biol. 17:4572
143. Gri G, Savio D, Trinchieri G, Ma X. 1998. Synergistic regulation of the human interleukin-12 p40 promoter by NFkappaB and Ets transcription factors in Epstein-Barr virus-transformed B cells and macrophages. J. Biol. Chem. 273:6431
144. Yoshimoto T, Nagase H, Ishida T, Inoue J, Nariuchi H. 1997. Induction of interleukin-12 p40 transcript by CD40 ligation via activation of nuclear factor-kappaB. Eur. J. Immunol. 27:3461
145. Shu U, Kiniwa M, Wu CY, Maliszewski C, Vezzio N, Hakimi J, Gately M, Delespesse G. 1995. Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur. J. Immunol. 25:1125
146. Armant M, Armitage R, Boiani N, Delespesse G, Sarfati M. 1996. Functional CD40 ligand expression on T lymphocytes in the absence of T cell receptor engagement: involvement in interleukin-2-induced interleukin-12 and interferon-gamma production. Eur. J. Immunol. 26:1430
147. + T cells in the absence of TCR ligation. J. Immunol. 161:3408
148. Avice MN, Sarfati M, Triebel F, Delespesse G, Demeure CE. 1999. Lymphocyte activation gene-3, a MHC class II ligand expressed on activated T cells, stimulates TNF-alpha and IL-12 production by monocytes and dendritic cells. J. Immunol. 162:2748
149. Na SY, Kang BY, Chung SW, Han SJ, Ma X, Trinchieri G, Im SY, Lee JW, Kim TS. 1999. Retinoids inhibit interleukin-12 production in macrophages through physical associations of retinoid X receptor and NFkappaB. J. Biol. Chem. 274:7674
150. Mazzeo D, Panina-Bordignon P, Recalde H, Sinigaglia F, D'Ambrosio D. 1998. Decreased IL-12 production and Th1 cell development by acetyl salicylic acid-mediated inhibition of NF-kappaB. Eur. J. Immunol. 28:3205
151. D'Ambrosio D, Cippitelli M, Cocciolo MG, Mazzeo D, Di Lucia P, Lang R, Sinigaglia F, Panina-Bordignon P. 1998. Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J. Clin. Invest. 101:252
152. Karp CL, Wysocka M, Wahl LM, Ahearn JM, Cuomo PJ, Sherry B, Trinchieri G, Griffin DE. 1996. Mechanism of suppression of cell-mediated immunity by measles virus. Science 273:228
153. Karp CL, Wysocka M, Ma X, Marovich M, Factor RE, Nutman T, Armant M, Wahl L, Cuomo P, Trinchieri G. 1998. Potent suppression of IL-12 production from monocytes and dendritic cells during endotoxin tolerance. Eur. J. Immunol. 28:3128
154. Fiorentino DF, Bond MW, Mosmann TR. 1989. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170:2081
155. Aste-Amezaga M, Ma X, Sartori A, Trinchieri G. 1998. Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10. J. Immunol. 160:5936
156. Kishore R, Tebo JM, Kolosov M, Hamilton TA. 1999. Cutting edge: clustered AU-rich elements are the target of IL-10-mediated mRNA destabilization in mouse macrophages. J. Immunol. 162:2457
157. Orange JS, Wolf SF, Biron CA. 1994. Effects of IL-12 on the response and susceptibility to experimental viral infections. J. Immunol. 152:1253
158. Orange JS, Wang B, Terhorst C, Biron CA. 1995. Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. 7. Exp. Med. 182:1045
159. Orange JS, Biron CA. 1996. Characterization of early IL-12, IFN-alphabeta, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. J. Immunol. 156:4746
160. Cousens LP, Orange JS, Su HC, Biron CA. 1997. Interferon-alpha/beta inhibition of interleukin 12 and interferon-gamma production in vitro and endogenously during viral infection. PNAS 94:634
161. Cousens LP, Peterson R, Hsu S, Dorner A, Altman JD, Ahmed R, Biron CA. 1999. Two roads diverged: Interferon alpha/beta-and interleukin 12-mediated pathways in promoting T cell interferon gamma responses during viral infection. J. Exp. Med. 189:1315
162. Monteiro JM, Harvey C, Trinchieri G. 1998. Role of interleukin-12 in primary influenza virus infection. J. Virol. 72:4825
163. + T cells. Annu. Rev. Immunol. 12:635
164. Huang H, Hu-Li J, Chen H, Ben-Sasson SZ, Paul WE. 1997. IL-4 and IL-13 production in differentiated T helper type 2 cells is not IL-4 dependent. J. Immunol. 159:3731
165. Nelms K, Keegan AD, Zamorano J, Ryan JJ, Paul WE. 1999. The IL-4 receptor: signaling mechanisms and biologic functions. Annu. Rev. Immunol. 17:701
166. Wang HY, Paul WE, Keegan AD. 1996. IL-4 function can be transferred to the IL-2 receptor by tyrosine containing sequences found in the IL-4 receptor alpha chain. Immunity 4:113
167. Ryan JJ, McReynolds LJ, Keegan A, Wang LH, Garfein E, Rothman P, Nelms K, Paul WE. 1996. Growth and gene expression are predominantly controlled by distinct regions of the human IL-4 receptor. Immunity 4:123
168. Hou J, Schindler U, Henzel WJ, Ho TC, Brasseur M, McKnight SL. 1994. An interleukin-4-induced transcription factor: IL-4 Slat. Science 265:1701
169. Quelle FW, Shimoda K, Thierfelder W, Fischer C, Kim A, Ruben SM, Cleveland JL, Pierce JH, Keegan AD, Nelms K. 1995. Cloning of murine Stat6 and human Stat6, Stat proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not required for mitogenesis. Mol. Cell. Biol. 15:3336
170. Hershey GK, Friedrich MF, Esswein LA, Thomas ML, Chatila TA. 1997. The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor [see comments]. N. Engl. J. Med. 337:1720
171. Wang HY, Shelburne CP, Zamorano J, Kelly AE, Ryan JJ, Keegan AD. 1999. Cutting edge: effects of an allergy-associated mutation in the human IL-4R alpha (Q576R) on human IL-4-induced signal transduction. J. Immunol. 162: 4385
172. Zamorano J, Keegan AD. 1998. Regulation of apoptosis by tyrosine-containing domains of IL-4R alpha: Y497 and Y713, but not the STAT6-docking tyrosines, signal protection from apoptosis. J. Immunol. 161:859
173. Ryan JJ, McReynolds LJ, Huang H, Nelms K, Paul WE. 1998. Characterization of a mobile Stat6 activation motif in the human IL-4 receptor. J. Immunol. 161:1811
174. Kaplan MH, Schindler U, Smiley ST, Grusby MJ. 1996. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 4:313
175. Takeda K, Tanaka T, Shi W, Matsumoto M, Minami M, Kashiwamura S, Nakanishi K, Yoshida N, Kishimoto T, Akira S. 1996. Essential role of Stat6 in IL-4 signalling. Nature 380:627
176. Shimoda K, van Deursen J, Sangster MY, Sarawar SR, Carson RT, Tripp RA, Chu C, Quelle FW, Nosaka T, Vignali DA, Doherty PC, Grosveld G, Paul WE, Ihle JN. 1996. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380:630
177. Murphy E, Shibuya K, Hosken N, Openshaw P, Maino V, Davis K, Murphy K, O'Garra A. 1996. Reversibility of T helper 1 and 2 populations is lost after long-term stimulation. J. Exp. Med. 183:901
178. Alexander WS, Starr R, Fenner JE, et al. 1999. SOCS1 is a critical inhibitor of interferon y signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell 98:597
179. Murphy KM, Murphy TL, Szabo SJ, Jacobson NG, Guler ML, Gorham JD, Gubler U. 1997. Regulation of IL-12 receptor expression in early T-helper responses implies two phases of Th1 differentiation: capacitance and development. Chem. Immunol. 68:54
180. Huang H, Paul WE. 1998. Impaired interleukin 4 signaling in T helper type 1 cells. J. Exp. Med. 187:1305
181. Losman JA, Chen XP, Hilton D, Rothman P. 1999. Cutting edge: SOCS-1 is a potent inhibitor of IL-4 signal transduction. J. Immunol. 162:3770
182. Yoshimura A, Ohkubo T, Kiguchi T, Jenkins NA, Gilbert DJ, Copeland NG, Hara T, Miyajima A. 1995. A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors. EMBO J. 14:2816
183. Starr R, Willson TA, Viney EM, Murray LJ, Rayner JR, Jenkins BJ, Gonda TJ, Alexander WS, Metcalf D, Nicola NA, Hilton DJ. 1997. A family of cytokine-inducible inhibitors of signalling. Nature 387:917
184. Endo TA, Masuhara M, Yokouchi M, Suzuki R, Sakamoto H, Mitsui K, Matsumoto A, Tanimura S, Ohtsubo M, Misawa H, Miyazaki T, Leonor N, Taniguchi T, Fujita T, Kanakura Y, Komiya S, Yoshimura A. 1997. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387:921
185. Naka T, Narazaki M, Hirata M, Matsumoto T, Minamoto S, Aono A, Nishimoto N, Kajita T, Taga T, Yoshizaki K, Akira S, Kishimoto T. 1997. Structure and function of a new STAT-induced STAT inhibitor. Nature 387:924
186. Minamoto S, Ikegame K, Ueno K, Narazaki M, Naka T, Yamamoto H, Matsumoto T, Saito H, Hosoe S, Kishimoto T. 1997. Cloning and functional analysis of new members of STAT induced STAT inhibitor (SSI) family: SSI-2 and SSI-3. Biochem. Biophys. Res. Commun. 237:79
187. Masuhara M, Sakamoto H, Matsumoto A, Suzuki R, Yasukawa H, Mitsui K, Wakioka T, Tanimura S, Sasaki A, Misawa H, Yokouchi M, Ohtsubo M, Yoshimura A. 1997. Cloning and characterization of novel CIS family genes. Biochem. Biophys. Res. Commun. 239:439
188. Hilton DJ, Richardson RT, Alexander WS, Viney EM, Willson TA, Sprigg NS, Starr R, Nicholson SE, Metcalf D, Nicola NA. 1998. Twenty proteins containing a C-terminal SOCS box form five structural classes. PNAS 95:114
189. Vasiliauskas D, Hancock S, Stern CD. 1999.SWiP-I: novel SOCS box containing WD-protein regulated by signalling centres and by Shh during development. Mech. Dev. 82:79
190. Dey BR, Spence SL, Nissley P, Furlanetto RW. 1998. Interaction of human suppressor of cytokine signaling (SOCS)-2 with the insulin-like growth factor-I receptor. J. Biol. Chem. 273:24095
191. Adams TE, Hansen JA, Starr R, Nicola NA, Hilton DJ, Billestrup N. 1998. Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling. 7. Biol. Chem. 273:1285
192. Bjorbaek C, Elmquist JK, Frantz JD, Shoelson SE, Flier JS. 1998. Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol. Cell 1:619
193. Helman D, Sandowski Y, Cohen Y, Matsumoto A, Yoshimura A, Merchav S, Gertler A. 1998. Cytokine-inducible SH2 protein (CIS3) and JAK2 binding protein (JAB) abolish prolactin receptor-mediated STAT5 signaling. FEBS Lett. 441:287
194. Sakamoto H, Yasukawa H, Masuhara M, Tanimura S, Sasaki A, Yuge K, Ohtsubo M, Ohtsuka A, Fujita T, Ohta T, Furukawa Y, Iwase S, Yamada H, Yoshimura A. 1998. A Janus kinase inhibitor, JAB, is an interferon-gamma-inducible gene and confers resistance to interferons. Blood 92:1668
195. Nicholson SE, Willson TA, Farley A, Starr R, Zhang JG, Baca M, Alexander WS, Metcalf D, Hilton DJ, Nicola NA. 1999. Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction. EMBO J. 18:375
196. Narazaki M, Fujimoto M, Matsumoto T, Monta Y, Saito H, Kajita T, Yoshizaki K, Naka T, Kishimoto T. 1998. Three distinct domains of SSI-1/SOCS-1/JAB protein are required for its suppression of interleukin 6 signaling. PNAS 95:13130
197. Yasukawa H, Misawa H, Sakamoto H, Masuhara M, Sasaki A, Wakioka T, Ohtsuka S, Imaizumi T, Matsuda T, Ihle JN, Yoshimura A. 1999. The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. EMBO J. 18:1309
198. Verdier F, Chretien S, Muller O, Varlet P, Yoshimura A, Gisselbrecht S, Lacombe C, Mayeux P. 1998. Proteasomes regulate erythropoietin receptor and signal transducer and activator of transcription 5 (STAT5) activation. Possible involvement of the ubiquitinated Cis protein. J. Biol. Chem. 273:28185
199. Kamura T, Sato S, Haque D, Liu L, Kaelin WGJ, Conaway RC, Conaway JW. 1998. The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. Genes Dev. 12:3872
200. Zhang JG, Farley A, Nicholson SE, Willson TA, Zugaro LM, Simpson RJ, Moritz RL, Cary D, Richardson R, Hausmann G, Kile BJ, Kent SB, Alexander WS , Metcalf D, Hilton DJ, Nicola NA, Baca M. 1999. The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation. PNAS 96:2071
201. Stebbins CE, Kaelin WGJ, Pavletich NP. 1999. Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function. Science 284:455
202. Verdier F, Rabionet R, Gouilleux F, Beisenherz-Huss C, Varlet P, Muller O, Mayeux P, Lacombe C, Gisselbrecht S, Chretien S. 1998. A sequence of the CIS gene promoter interacts preferentially with two associated STAT5 A dimers: a distinct biochemical difference between STAT5A and STAT5B. Mol. Cell. Biol. 18:5852
203. Matsumoto A, Masuhara M, Mitsui K, Yokouchi M, Ohtsubo M, Misawa H, Miyajima A, Yoshimura A. 1997. CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation. Blood 89:3148
204. Auernhammer CJ, Bousquet C, Melmed S, 1999. Autoregulation of pituitary corticotroph SOCS-3 expression: characterization of the murine SOCS-3 promoter. PNAS 96:6964
205. Song MM, Shuai K. 1998. The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and anti-proliferative activities. J. Biol. Chem. 273:35056
206. Venkataraman C, Leung S, Salvekar A, Mano H, Schindler U. 1999. Repression of IL-4-induced gene expression by IFN-gamma requires Stat1 activation. J. Immunol. 162:4053
207. Dickensheets HL, Donnelly RP. 1999. Inhibition of IL-4-inducible gene expression in human monocytes by type I and type II interferons. J. Leuk. Biol. 65:307
208. Starr R, Metcalf D, Elefanty AG, Brysha M, Willson TA, Nicola NA, Hilton DJ, Alexander WS. 1998. Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. PNAS 95:14395
209. Naka T, Matsumoto T, Narazaki M, Fujimoto M, Monta Y, Ohsawa Y, Saito H, Nagasawa T, Uchiyama Y, Kishimoto T. 1998. Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice. PNAS 95:15577
210. Metcalf D, Alexander WS, Elefanty AG, Nicola NA, Hilton DJ, Starr R, Mifsud S, Di Rago L. 1999. Aberrant hematopoiesis in mice with inactivation of the gene encoding SOCS-1. Leukemia 13:926
211. Cohney SJ, Sanden D, Cacalano NA, Yoshimura A, Mui A, Migone TS, Johnston JA. 1999. SOCS-3 is tyrosine phos-phorylated in response to interleukin-2 and suppresses STAT5 phosphorylation and lymphocyte proliferation. Mol. Cell. Biol. 19, 4980-88, 7-99
212. Bach EA, Szabo SJ, Dighe AS, Ashkenazi A, Aguet M, Murphy KM, Schreiber RD. 1995. Ligand-induced autoregulation of IFN-gamma receptor beta chain expression in T helper cell subsets. Science 270:1215
213. Pernis A, Gupta S, Gollob KJ, Garfein E, Coffman RL, Schindler C, Rothman P. 1995. Lack of interferon gamma receptor beta chain and the prevention of interferon gamma signaling in TH1 cells [see comments]. Science 269:245
214. Kubo M, Ransom J, Webb D, Hashimoto Y, Tada T, Nakayama T. 1997. T-cell subset-specific expression of the IL-4 gene is regulated by a silencer element and STAT6. EMBO J. 16:4007
215. Szabo SJ, Glimcher LH, Ho IC. 1997. Genes that regulate interleukin-4 expression in T cells. Curr. Opinion Immunol. 9:776
216. Rao A, Luo C, Hogan PG. 1997. Transcription factors of the NFAT family: regulation and function. Anna. Rev. Immunol. 15:707
217. Xanthoudakis S, Viola JP, Shaw KT, Luo C, Wallace JD, Bozza PT, Luk DC, Curran T, Rao A. 1996. An enhanced immune response in mice lacking the transcription factor NFAT1 Science 272:892
218. Hodge MR, Ranger AM, Charles d1B, Hoey T, Grusby MJ, Glimcher LH. 1996. Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice. Immunity 4:397
219. Kiani A, Viola JP, Lichtman AH, Rao A. 1997. Down-regulation of IL-4 gene transcription and control of Th2 cell differentiation by a mechanism involving NFAT1. Immunity 7:849
220. Viola JP, Kiani A, Bozza PT, Rao A. 1998. Regulation of allergic inflammation and eosinophil recruitment in mice lacking the transcription factor NFAT1: role of interleukin-4 (IL-4) and IL-5. Blood 91:2223
221. Heyer J, Kneitz B, Schuh K, Jankevics E, Siebelt F, Schimpl A, Serfling E. 1997. Inefficient termination of antigen responses in NF-ATp-deficient mice. Immunobiology 198:162
222. Schuh K, Kneitz B, Heyer J, Bommhardt U, Jankevics E, Berberich-Siebelt F, Pfeffer K, Muller-Hermelink HK, Schimpl A, Serfling E. 1998. Retarded thymic involution and massive germinal center formation in NF-ATp-deficient mice. Eur. J. Immunol. 28:2456
223. Ranger AM, Hodge MR, Gravallese EM, Oukka M, Davidson L, AIt FW, de la Brousse FC, Hoey T, Grusby M, Glimcher LH. 1998. Delayed lymphoid repopulation with defects in IL-4-driven responses produced by inactivation of NF-ATc. Immunity i:125
224. Yoshida H, Nishina H, Takimoto H, Marengere LE, Wakeham AC, Bouchard D, Kong YY, Ohteki T, Shahinian A, Bachmann M, Ohashi PS, Penninger JM, Crabtree GR, Mak TW. 1998. The transcription factor NF-ATc1 regulates lymphocyte proliferation and Th2 cytokine production. Immunity 8:115
225. Oukka M, Ho IC, de la Brousse FC, Hoey T, Grusby MJ, Glimcher LH. 1998. The transcription factor NFAT4 is involved in the generation and survival of T cells. Immunity 9:295
226. Ranger AM, Oukka M, Rengarajan J, Glimcher LH. 1998. Inhibitory function of two NFAT family members in lymphoid homeostasis and Th2 development. Immunity 9:627
227. Garcia-Rodriguez C, Rao A. 1998. Nuclear factor of activated T cells (NFAT)-dependent transactivation regulated by the coactivators p300/CREB-binding protein (CBP). J. Exp. Med. 187:2031
228. Chuvpilo S, Zimmer M, Kerstan A, Glockner J, Avots A, Escher C, Fischer C, Inashkina I, Jankevics E, Berberich-Siebelt F, Schmitt E, Serfling E. 1999. Alternative polyadenylation events contribute to the induction of NF-ATc in effector T cells. Immunity 10:261
229. Kim JI, Li T, Ho IC, Grusby MJ, Glimcher LH. 1999. Requirement for the c-Maf transcription factor in crystallin gene regulation and lens development. PNAS 96:3781
230. Kim JI, Ho IC, Grusby MJ, Glimcher LH. 1999. The transcription factor c-Maf controls the production of interleukin-4 but not other Th2 cytokines. Immunity 10:745-51
231. Dent AL, Shaffer AL, Yu X, Allman D, Staudt LM. 1997. Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science 276:589
232. Dent AL, Hu-Li J, Paul WE, Staudt LM. 1998. T helper type 2 inflammatory disease in the absence of interleukin 4 and transcription factor STAT6. PNAS 95:13823
233. + T helper 2 (Th2) cells but not in Th1 cells. Mol. Cell. Biol. 17:1522
234. + T-cells into effector Th1 and Th2 cells. Genes Function 1:51
235. Szabo SJ, Gold JS, Murphy TL, Murphy KM. 1993. Identification of cis-acting regulatory elements controlling interleukin-4 gene expression in T cells: roles for NF-Y and NF-ATc. Mol. Cell. Biol. 13:4793
236. Li-Weber M, Salgame P, Hu C, Davydov LV, Laur O, Klevenz S, Krammer PH. 1998. Th2-specific protein/DNA interactions at the proximal nuclear factor-AT site contribute to the functional activity of the human IL-4 promoter. J. Immunol. 161:1380
237. Chen L, Glover JN, Hogan PG, Rao A, Harrison SC. 1998. Structure of the DNA-binding domains from NFAT, Fos and Jun bound specifically to DNA. Nature 392:42
238. Li B, Tournier C, Davis RJ, Flavell RA. 1999. Regulation of IL-4 expression by the transcription factor JunB during T helper cell differentiation. EMBO J. 18:420
239. Pandolfi PP, Roth ME, Karis A, Leonard MW, Dzierzak E, Grosveld FG, Engel JD, Lindenbaum MH. 1995. Targeted disruption of the GATA3 gene causes severe abnormalities in the nervous system and in fetal liver haematopoiesis. Nat. Genet. 11:40
240. Ting CN, Olson MC, Barton KP, Leiden JM. 1996. Transcription factor GATA-3 is required for development of the T-cell lineage. Nature 384:474
241. Hendriks RW, Nawijn MC, Engel JD, van Doorninck H, Grosveld F, Karis A. 1999. Expression of the transcription factor GATA-3 is required for the development of the earliest T cell progenitors and correlates with stages of cellular proliferation in the thymus. Eur. J. Immunol. 29(6):1912-18
242. Zheng W, Flavell RA. 1997. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89:587
243. Zhang DH, Cohn L, Ray P, Bottomly K, Ray A. 1997. Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene. J. Biol. Chem. 272:21597
244. Zhang DH, Yang L, Ray A. 1998. Differential responsiveness of the IL-5 and IL-4 genes to transcription factor GATA-3. J. Immunol. 161:3817
245. Siegel MD, Zhang DH, Ray P, Ray A. 1995. Activation of the interleukin-5 promoter by cAMP in murine EL-4 cells requires the GATA-3 and CLEO elements. J. Biol. Chem. 270:24548
246. Lee HJ, O'Garra A, Arai K, Arai N. 1998. Characterization of cis-regulatory elements and nuclear factors conferring Th2-specific expression of the IL-5 gene: a role for a GATA-binding protein. J. Immunol. 160:2343
247. Ranganath S, Ouyang W, Bhattarcharya D, Sha WC, Grupe A, Peltz G, Murphy KM. 1998. GATA-3-dependent enhancer activity in IL-4 gene regulation. J. Immunol. 161:3822
248. Ferber IA, Lee HJ, Zonin F, HeathV, Mui A, Arai N, O'Garra A. 1999. GATA-3 significantly downregulates IFN-gamma production from developing Th1 cells in addition to inducing IL-4 and IL-5 levels. Clin. Immunol. 91:134
249. Nakamura Y, Ghaffar O, Olivenstein R, Taha RA, Soussi-Gounni A, Zhang DH, Ray A, Hamid Q. 1999. Gene expression of the GATA-3 transcription factor is increased in atopic asthma. J. Allergy Clin. Immunol. 103:215
250. Curiel RE, Lahesmaa R, Subleski J, Cippitelli M, Kirken RA, Young HA, Ghosh P. 1997. Identification of a Stat-6-responsive element in the promoter of the human interleukin-4 gene. Eur. J. Immunol. 27:1982
251. Georas SN, Cumberland JE, Burke TF, Chen R, Schindler U, Casolaro V. 1998. Stat6 inhibits human interleukin-4 promoter activity in T cells. Blood 92:4529
252. Lederer JA, Perez VL, DesRoches L, Kim SM, Abbas AK, Lichtman AH. 1996. Cytokine transcriptional events during helper T cell subset differentiation. J. Exp. Med. 184:397
253. Minty A, Chalon P, Derocq JM, Dumont X, Guillemot JC, Kaghad M, Labit C, Leplatois P, Liauzun P, Miloux B. 1993. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 362:248
254. Chomarat P, Banchereau J. 1998. Interleukin-4 and interleukin-13: their similarities and discrepancies. Int. Rev. Immunol. 17:1
255. Wills-Karp M, Luyimbazi J, Xu X, Schofleld B, Neben TY, Karp CL, Donaldson DD. 1998. Interleukin-13: central mediator of allergic asthma. Science 282:2258
256. Wills-Karp M. 1999. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu. Rev. Immunol. 17:255-81
257. McKenzie GJ, Emson CL, Bell SE, Anderson S, Fallon P, Zurawski G, Murray R, Grencis R, McKenzie AN. 1998. Impaired development of Th2 cells in IL-13-deficient mice. Immunity 9:423
258. Graber P, Gretener D, Herren S, Aubry JP, Elson G, Poudrier J, Lecoanet-Henchoz S, Alouani S, Losberger C, Bonnefoy JY, Kosco-Vilbois MH, Gauchat JF. 1998. The distribution of IL-13 receptor alpha1 expression on B cells, T cells and monocytes and its regulation by IL-13 and IL-4. Eur. J. Immunol. 28:4286
259. Urban JFJ, Maliszewski CR, Madden KB, Katona IM, Finkelman FD. 1995. IL-4 treatment can cure established gastrointestinal nematode infections in immunocompetent and immunodeficient mice. J. Immunol. 154:4675
260. Lawrence RA, Gray CA, Osborne J, Maizels RM. 1996. Nippostrongylus brasiliensis: cytokine responses and nematode expulsion in normal and IL-4-deficient mice. Exp. Parasitol. 84:65
261. Murphy KM. 1998. T lymphocyte differentiation in the periphery. Curr. Opin. Immunol. 10:226
262. + T cell IL-4 production is revealed in IL-4 receptor-deficient mice. PNAS 94:10838
263. Urban JFJ, Noben-Trauth N, Donaldson DD, Madden KB, Morris SC, Collins M, Finkelman FD. 1998. IL-13, IL-4Ralpha, and Stat6 are required for the expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis. Immunity 8:255
264. Barner M, Mohrs M, Brombacher F, Kopf M. 1998. Differences between IL-4R alpha-deficient and IL-4-deficient mice reveal a role for IL-13 in the regulation of Th2 responses. Curr. Biol. 8:669
265. Rissoan MC, Soumelis V, Kadowaki N, Grouard G, Briere F, de Waal M, Liu YJ. 1999. Reciprocal control of T helper cell and dendritic cell differentiation [see comments]. Science 283:1183
266. Pulendran B, Smith JL, Caspary G, Brasel K, Pettit D, Maraskovsky E, Maliszewski CR. 1999. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. PNAS 96:1036
267. Siegal FP, Kadowaki N, Shodell M, Fitzgerald-Bocarsly PA, Shah K, Ho S, Antonenko S, Liu YJ. 1999. The nature of the principal type 1 interferon-producing cells in human blood. Science 284:1835
268. + T cells can be primed in vitro to produce IL-4. J. Immunol. 148:1652
269. + T cells: their activation and effector functions. Curr. Opin. Immunol. 6:453
270. Mosmann TR, Li L, Sad S. 1997. Functions of CD8 T-cell subsets secreting different cytokine patterns. Semin. Immunol. 9:87
271. + T cells secreting Th1 or Th2 cytokines. Immunity 2:271
272. Croft M, Carter L, Swain SL, Dutton RW. 1994. Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles. J. Exp. Med. 180:1715
273. Fowell DJ, Magram J, Turck CW, Killeen N, Locksley RM. 1997. Impaired Th2 subset development in the absence of CD4. Immunity 6:559
274. Brown DR, Moskowitz NH, Killeen N, Reiner SL. 1997. A role for CD4 in peripheral T cell differentiation. J. Exp. Med. 186:101
275. Veillette A, Bookman MA, Horak EM, Bolen JB. 1988. The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lck. Cell 55:301
276. Turner JM, Brodsky MH, Irving BA, Levin SD, Perlmutter RM, Littman DR. 1990, Interaction of the unique N-terminal region of tyrosine kinase p56lck with cytoplasmic domains of CD4 and CD8 is mediated by cysteine motifs. Cell 60:755
277. Yamashita M, Hashimoto K, Kimura M, Kubo M, Tada T, Nakayama T. 1998. Requirement for p56(lck) tyrosine kinase activation in Th subset differentiation. Int. Immunol. 10:577
278. Yu CL, Jove R, Burakoff SJ. 1997. Constitutive activation of the Janus kinase-STAT pathway in T lymphoma overexpressing the Lck protein tyrosine kinase. J. Immunol. 159:5206
279. Heyeck SD, Wilcox HM, Bunnell SC, Berg LJ. 1997. Lck phosphorylates the activation loop tyrosine of the Itk kinase domain and activates Itk kinase activity. J. Biol. Chem. 272:25401
280. Liao XC, Littman DR. 1995. Altered T cell receptor signaling and disrupted T cell development in mice lacking ltk. Immunity 3:757
281. Liu KQ, Bunnell SC, Gurniak CB, Berg LJ. 1998. T cell receptor-initiated calcium release is uncoupled from capacitative calcium entry in Ilk-deficient T cells. J. Exp. Med. 187:1721
282. Gajewski TF, Schell SR, Fitch FW. 1990. Evidence implicating utilization of different T cell receptor-associated signaling pathways by TH1 and TH2 clones. J. Immunol. 144:4110
283. Sloan-Lancaster J, Steinberg TH, Allen PM. 1997. Selective loss of the calcium ion signaling pathway in T cells maturing toward a T helper 2 phenotype. J. Immunol. 159:1160
284. + cytotoxic T cells after stimulation with T cell agonists, partial agonists and antagonists. Eur. J. Immunol. 27:3414
285. + signaling modulates cytolytic T lymphocyte effector functions. J. Exp. Med. 187:1057
286. + signals and immunosuppression. Nature 383:837
287. + response amplitude and duration [see comments] [published erratum appears in Nature 1997 Jul 17; 388(6639):308]. Nature 386:855
288. + response amplitude and duration [see comments] [published erratum appears in Nature 1997 Jul 17; 388(6639):308]. Nature 386:855
289. + T lymphocytes. J. Clin. Immunol. 15:232
290. Yamashita M, Kimura M, Kubo M, Shimizu C, Tada T, Perlmutter RM, Nakayama T. 1999. T cell antigen receptor-mediated activation of the Ras/ mitogen-activated protein kinase pathway controls interleukin 4 receptor function and type-2 helper T cell differentiation. PNAS 96:1024
291. Dasen JS, O'Connell SM, Flynn SE, Treier M, Gleiberman AS, Szeto DP, Hooshmand F, Aggarwal AK, Rosenfeld MG, Rosenfeld M. 1999. Reciprocal interactions of Pit1 and GATA2 mediate signaling gradient-induced determination of pituitary cell types. Cell 97:587
292. Coffman RL, Mocci S, O'Garra A. 1999. The stability and reversibility of Th1 and Th2 populations. Curr. Top. Microbiol. Immunol. 238:1
293. Minasi LE, Kamogawa Y, Carding S, Bottomly K, Flavell RA. 1993. The selective ablation of interleukin 2-producing cells isolated from transgenic mice. J. Exp. Med. 177:1451
294. Kamogawa Y, Minasi LA, Carding SR, Bottomly K, Flavell RA. 1993. The relationship of IL-4-and IFN gamma-producing T cells studied by lineage ablation of IL-4-producing cells. Cell 75:985
295. + T cells. J. Immunol. 158:1085
296. Szabo SJ, Dighe AS, Gubler U, Murphy KM. 1997. Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J. Exp. Med. 185:817
297. Mocci S, Coffman RL. 1995. Induction of a Th2 population from a polarized Leishmania-specific Th1 population by in vitro culture with IL-4. J. Immunol. 154:3779
298. Mocci S, Coffman RL. 1997. The mechanism of in vitro T helper cell type 1 to T helper cell type 2 switching in highly polarized Leishmania major-specific T cell populations. J. Immunol. 158:1559
299. Hollander GA, Zuklys S, Morel C, Mizoguchi E, Mobisson K, Simpson S, Terhorst C, Wishart W, Golan DE, Bhan AK, Burakoff SJ. 1998. Monoallelic expression of the interleukin-2 locus [see comments]. Science 279:2118
300. Shibahara K, Stillman B. 1999. Replication-dependent marking of DNA by PCNA facilitates CAF-1-coupled inheritance of chromatin. Cell 96:575
301. + T cells. Science 281:1352
302. Naramura M, Hu RJ, Gu H. 1998. Mice with a fluorescent marker for inlerleukin 2 gene activation. Immunity 9:209
303. Riviere I, Sunshine MJ, Littman DR. 1998. Regulation of IL-4 expression by activation of individual alleles. Immunity 9:217
304. Bird JJ, Brown DR, Mullen AC, Moskowitz NH, Mahowald MA, Sider JR, Gajewski TF, Wang CR, Reiner SL. 1998. Helper T cell differentiation is controlled by the cell cycle. Immunity 9:229
305. Gett AV, Hodgkin PD. 1998. Cell division regulates the T cell cytokine repertoire, revealing a mechanism underlying immune class regulation. PNAS 95:9488
306. Takemoto N, Koyano-Nakagawa N, Yokota T, Arai N, Miyatake S, Arai K. 1998. Th2-specific DNase I-hypersensitive sites in the murine L-13 and IL-4 intergenic region. Int. Immunol. 10:1981
307. Ye J, Young HA. 1997. Negative regulation of cytokine gene transcription. FASEB J. 11:825
308. + T lymphocytes. J. Immunol. 162:5053
309. Meraz MA, White JM, Sheehan KC, Bach EA, Rodig SJ, Dighe AS, Kaplan DH, Riley JK, Greenlund AC, Campbell D, Carver-Moore K, DuBois RN, Clark R, Aguet M, Schreiber RD. 1996. Targeted disruption of the Stal1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84:431
310. Kopf M, Le Gros G, Bachmann M, Lamers MC, Bluethmann H, Kohler G. 1993. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362:245